Rapid SDH vs Illumeo System
AI Verdict
Choose Rapid SDH if…
Choose Rapid SDH if your primary need is the immediate and highly accurate AI-powered detection of suspected subdural hematomas on CT scans, particularly in acute neurocritical care settings. This tool is ideal for accelerating time-sensitive clinical decisions and expediting patient care by delivering critical notifications in under a minute.
View Rapid SDH →Choose Illumeo System if…
Choose Philips Illumeo if your institution seeks a comprehensive imaging and informatics platform that leverages adaptive intelligence to enhance overall radiologist efficiency and diagnostic consistency across a wide range of imaging studies. This system is best suited for augmenting clinician skills, providing advanced data analytics, and integrating seamlessly with existing PACS/EMR/RIS to standardize workflows and reduce variability.
View Illumeo System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid SDH | Illumeo System |
|---|---|---|
| Pricing | Contact vendor | Not publicly available |
| Deployment | Cloud-based, On-premise | Integrates with existing healthcare IT systems (e.g., Philips IntelliSpace PACS, EMR/RIS); Enterprise viewer is HTML5-based and zero-footprint. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid SDHRapid SDH excels in usability by providing rapid, automated notifications for critical conditions in under a minute, integrating seamlessly with mobile apps, PACS, and email. This direct and immediate delivery of actionable insights minimizes cognitive burden and streamlines decision-making for clinicians. Illumeo offers adaptive intelligence and a zero-footprint viewer, but Rapid SDH's focus on speed and accessibility for time-sensitive diagnoses gives it an edge in immediate, impactful usability.
Clinical Value
Rapid SDHRapid SDH demonstrates clear and quantifiable clinical value with a high positive predictive value of 99% (93% sensitivity, 99% specificity) for detecting subdural hematomas greater than 1ml. This specific, validated accuracy for a life-threatening condition provides a direct and measurable impact on patient care. While Illumeo aims to enhance overall diagnostic confidence and efficiency, its clinical benefits are described in broader terms without the same level of specific, published performance metrics for a particular disease.
Pricing & Value
Rapid SDHBoth tools have opaque pricing, requiring direct vendor contact. However, Rapid SDH provides more explicit examples of its value proposition through demonstrated time savings for technologists and potential incremental revenue gains for hospitals. This direct correlation between its clinical utility and measurable financial benefits offers a clearer understanding of its potential return on investment.
Enterprise Readiness
Illumeo SystemBoth tools are FDA-cleared, HIPAA compliant, and offer BAA, with flexible deployment options. Philips Illumeo, as part of the broader Philips IntelliSpace Enterprise Edition, leverages Philips' extensive experience in large-scale healthcare IT deployments and its proven ability to integrate across multiple departments and with various medical devices. This is evidenced by significant enterprise contracts, showcasing a comprehensive and deeply integrated approach to hospital-wide solutions.
Innovation
Rapid SDHRapid SDH showcases innovation through its highly accurate and rapid AI-powered detection of critical conditions, expanding into a comprehensive platform for hemorrhagic and trauma care and beyond. Its focus on 'deep clinical AI' and co-development of foundational AI models, coupled with its pioneering status and measurable impact in extending stroke treatment windows, demonstrates a strong forward-looking innovation strategy.
Support & Docs
Rapid SDHRapidAI explicitly offers 24/7/365 customer support via phone and email, along with a robust library of resources including expert guides, videos, whitepapers, and FAQs. While Philips, as a large enterprise, provides support, the specific and detailed commitment to 24/7/365 availability and comprehensive, readily accessible documentation for the Illumeo System is not as clearly articulated in public information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid SDH | Illumeo System |
|---|---|---|
| Name | Rapid SDH | Illumeo System |
| Company | RapidAI (formerly iSchemaView) | Philips Medical Systems Technologies |
| Tagline | Where AI meets patient care. | Adaptive Intelligence Technology for Radiology |
| Description | Rapid SDH by RapidAI is an FDA-cleared AI module that rapidly detects suspected acute and chronic subdural hematomas on CT scans, delivering notifications in under a minute to accelerate neurocritical care decisions. | Philips Illumeo is an imaging and informatics platform with adaptive intelligence (AI) that augments clinicians' skills and redefines how they interact with images, enhancing their expertise and efficiency, and supporting variability reduction throughout the institution. |
| Categories | Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI | Radiology & Imaging AI |
Videos
Demos, reviews, and walkthroughs featuring Rapid SDH and Illumeo System.